Skip to Content

Omeprazole / sodium bicarbonate Pregnancy and Breastfeeding Warnings

Omeprazole / sodium bicarbonate is also known as: Zegerid, Zegerid OTC

Omeprazole / sodium bicarbonate Pregnancy Warnings

Epidemiological data have failed to reveal evidence of an increased risk of congenital malformations or other outcomes when patients took this drug during the first trimester. Animal models have revealed evidence of bone morphology changes in offspring exposed to high doses throughout pregnancy and lactation. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. US FDA pregnancy category: C

See references

Omeprazole / sodium bicarbonate Breastfeeding Warnings

Following an oral dose of 20 mg, the peak concentration of omeprazole in breast milk was less than 7% of the mother's peak serum concentration, or a dose of approximately 0.004 mg of omeprazole in 200 mL of milk.

Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes (omeprazole); Data not available (sodium bicarbonate) Excreted into animal milk: Data not available (sodium bicarbonate) Comment: This drug may cause serious adverse events and/or tumorigenicity in breastfed neonates and infants.

See references

References for pregnancy information

  1. "Product Information. Zegerid (omeprazole-sodium bicarbonate)." Santarus Inc, San Diego, CA.
  2. "Product Information. Zegerid (omeprazole)." Santarus Inc, San Diego, CA.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Zegerid (omeprazole-sodium bicarbonate)." Santarus Inc, San Diego, CA.
  3. "Product Information. Zegerid (omeprazole)." Santarus Inc, San Diego, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.